Dunyan Yao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dunyan Yao has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Masahiro Ohsawa
Laboratory of Systems Pharmacology, Faculty of Pharmaceutical Sciences, Teikyo University, Tokyo, Japan
2 shared publications - Metin Akay
Department of Biomedical Engineering, Cullen College of Engineering, University of Houston, Houston, TX 77204, USA
2 shared publications - Airi Kamata
Laboratory of Systems Pharmacology, Faculty of Pharmaceutical Sciences, Teikyo University, Tokyo 173-8605, Japan
1 shared publication - Austin Ganaway
Biomedical Engineering Department, University of Houston, 3517 Cullen Blvd, Houston, TX 77204, USA
1 shared publication - David Anderson Lloyd
Biomedical Engineering Department, University of Houston, Houston, TX, USA
1 shared publication - Jun Ohta
Nara Institute of Science and Technology
1 shared publication
Latest Publications
- 3 November 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Journal of Biomedical and Health Informatics
- Vol. 30 (5) , 3934-3945
AI-Based Localized Latent Neural Representations of Acute and Chronic Pain in Rats
Chronic pain is a widespread phenomenon affecting over 21% of the United States population. Despite the significant impact of pain on a patient's quality of life, the detection and identification of pain relies on subjective methods such as self-reporting. To address the challenges in identifying and treating chronic pain, a quantifiable biomarker for pain is needed. Here we present novel AI-driven method for the identification and isolation of localized pain signals in the brain during both acute and chronic pain. By using Matching Pursuit (MP) to decompose Local Field Potential (LFP) recordings from the Anterior Cingulate Cortex, the Nucleus Accumbens, and the Prelimbic Cortex, we can learn a latent representation with a conditional variational autoencoder (CVAE) and track changes in latent signal components in response to acute, sub-chronic, and chronic pain after injury. This method allows for both the identification of LFP signal components which are the primary drivers of observed aggregate changes in brain activity during pain, as well as for the tracking of said components over time. The model achieves an average per-feature RMSE of 0.130 on validation data and produces functionally separable latent representations of input MP atoms. The combination of MP for feature extraction and CVAE for latent space development allows for the extraction of both generalized and subject-specific pain motifs involved in chronic pain. These AI-driven biomarkers provide a basis for precision identification and quantitative monitoring of pain over time.
- 3 November 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Journal of Biomedical and Health Informatics
- Vol. 30 (5) , 3934-3945
AI-Based Localized Latent Neural Representations of Acute and Chronic Pain in Rats
Chronic pain is a widespread phenomenon affecting over 21% of the United States population. Despite the significant impact of pain on a patient's quality of life, the detection and identification of pain relies on subjective methods such as self-reporting. To address the challenges in identifying and treating chronic pain, a quantifiable biomarker for pain is needed. Here we present novel AI-driven method for the identification and isolation of localized pain signals in the brain during both acute and chronic pain. By using Matching Pursuit (MP) to decompose Local Field Potential (LFP) recordings from the Anterior Cingulate Cortex, the Nucleus Accumbens, and the Prelimbic Cortex, we can learn a latent representation with a conditional variational autoencoder (CVAE) and track changes in latent signal components in response to acute, sub-chronic, and chronic pain after injury. This method allows for both the identification of LFP signal components which are the primary drivers of observed aggregate changes in brain activity during pain, as well as for the tracking of said components over time. The model achieves an average per-feature RMSE of 0.130 on validation data and produces functionally separable latent representations of input MP atoms. The combination of MP for feature extraction and CVAE for latent space development allows for the extraction of both generalized and subject-specific pain motifs involved in chronic pain. These AI-driven biomarkers provide a basis for precision identification and quantitative monitoring of pain over time.
- Open Access
- 7 July 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (13) , 6526
Mapping Morphine’s Antinociceptive Impact on the Ventral Tegmental Area During Nociceptive Stimulation: A Novel Microimaging Approach in a Neuropathic Pain Model
The neurobiology of chronic pain is complex and multifaceted, intertwining with the mesocorticolimbic system to regulate the behavioral and perceptional response to adverse stimuli. Specifically, the ventral tegmental area (VTA), the dopaminergic hub of the reward pathways located deep within the midbrain, is crucial for regulating the release of dopamine (DA) throughout the central nervous system (CNS). To better understand the nuances among chronic pain, VTA response, and therapeutics, implementing progressive approaches for mapping and visualizing the deep brain in real time during nociceptive stimulation is crucial. In this study, we utilize a fluorescence imaging platform with a genetically encoded calcium indicator (GCaMP6s) to directly visualize activity in the VTA during acute nociceptive stimulation in both healthy adult mice and adult mice with partial nerve ligation (PNL)-induced neuropathic pain. We also investigate the visualization of the analgesic properties of morphine. Deep brain imaging using our self-fabricated µ-complementary metal–oxide–semiconductor (CMOS) imaging device allows the tracking of the VTA’s response to adverse stimuli. Our findings show that nociceptive stimulation is associated with a reduction in VTA fluorescence activity, supporting the potential of this platform for visualizing pain-related responses in the central nervous system. Additionally, treatment with morphine significantly reduces the neuronal response caused by mechanical stimuli and is observable using the CMOS imaging platform, demonstrating a novel way to potentially assess and treat neuropathic pain.
- 7 July 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (13) , 6526
Open AccessMapping Morphine’s Antinociceptive Impact on the Ventral Tegmental Area During Nociceptive Stimulation: A Novel Microimaging Approach in a Neuropathic Pain Model
The neurobiology of chronic pain is complex and multifaceted, intertwining with the mesocorticolimbic system to regulate the behavioral and perceptional response to adverse stimuli. Specifically, the ventral tegmental area (VTA), the dopaminergic hub of the reward pathways located deep within the midbrain, is crucial for regulating the release of dopamine (DA) throughout the central nervous system (CNS). To better understand the nuances among chronic pain, VTA response, and therapeutics, implementing progressive approaches for mapping and visualizing the deep brain in real time during nociceptive stimulation is crucial. In this study, we utilize a fluorescence imaging platform with a genetically encoded calcium indicator (GCaMP6s) to directly visualize activity in the VTA during acute nociceptive stimulation in both healthy adult mice and adult mice with partial nerve ligation (PNL)-induced neuropathic pain. We also investigate the visualization of the analgesic properties of morphine. Deep brain imaging using our self-fabricated µ-complementary metal–oxide–semiconductor (CMOS) imaging device allows the tracking of the VTA’s response to adverse stimuli. Our findings show that nociceptive stimulation is associated with a reduction in VTA fluorescence activity, supporting the potential of this platform for visualizing pain-related responses in the central nervous system. Additionally, treatment with morphine significantly reduces the neuronal response caused by mechanical stimuli and is observable using the CMOS imaging platform, demonstrating a novel way to potentially assess and treat neuropathic pain.